Showing results (31-40 of 335) with videos related to
Sort By:
Pageof 34
Dialogues in Clinical Neuroscience|October 21, 2016
Neuropsychiatric genomics in precision medicine: diagnostics, gene discovery, and translationAnna C Need, David B GoldsteinMolecular Genetics & Genomic Medicine|November 14, 2022
Using reported pathogenic variants to identify therapeutic opportunities for genetic diseasesAndrew K Ressler, David B GoldsteinDialogues in Clinical Neuroscience|April 9, 2010
Whole genome association studies in complex diseases: where do we stand?Anna C Need, David B GoldsteinPlos Genetics|October 2, 2023
Neurodevelopmental deficits and cell-type-specific transcriptomic perturbations in a mouse model of HNRNPU haploinsufficiencySarah A Dugger, Ryan S Dhindsa, Gabriela De Almeida Sampaio, et al.Epilepsia|January 15, 2022
Association of ultra-rare coding variants with genetic generalized epilepsy: A case-control whole exome sequencing studyMahmoud Koko, Joshua E Motelow, Kate E Stanley, et al.Frontiers in Cellular Neuroscience|June 5, 2023
Epilepsy in a mouse model of GNB1 encephalopathy arises from altered potassium (GIRK) channel signaling and is alleviated by a GIRK inhibitorSophie Colombo, Haritha P Reddy, Sabrina Petri, et al.Current Biology : CB|January 16, 2003
Demography, recombination hotspot intensity, and the block structure of linkage disequilibriumMichael P H Stumpf, David B GoldsteinTrends in Biotechnology|May 20, 2015
Academic-industrial partnerships in drug discovery in the age of genomicsTim Harris, Stelios Papadopoulos, David B GoldsteinNature Reviews. Drug Discovery|December 9, 2017
Drug development in the era of precision medicineSarah A Dugger, Adam Platt, David B GoldsteinExpert Opinion on Pharmacotherapy|July 15, 2005
The role of common variation in drug transporter genes in refractory epilepsyNicole Soranzo, David B Goldstein, Sanjay M SisodiyaPageof 34